Clinical trial
Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis and Candidates With a Biological Monotherapy
NCT02087696 is registered in ClinicalTrials.gov with Spanish Foundation of Rheumatology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis and Candidates With a Biological Monotherapy
- Lead sponsor
- Spanish Foundation of Rheumatology
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 31, 2014
- Completion date
- July 31, 2016
- Enrollment
- 122 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.